Putting Malta at the forefront: €150K boost for MINDS Parkinson’s researchTitle:

Malta is stepping up its ambition to lead in medical research with a €150,000 investment in the “MINDS” project, a biomedical initiative at the University of Malta aimed at transforming the understanding and care of Parkinson’s in Malta. Malta is stepping up its ambition to lead in medical research with a €150,000 investment in the […]

Malta is stepping up its ambition to lead in medical research with a €150,000 investment in the “MINDS” project, a biomedical initiative at the University of Malta aimed at transforming the understanding and care of Parkinson’s in Malta.

Malta is stepping up its ambition to lead in medical research with a €150,000 investment in the “MINDS” project, a biomedical initiative at the University of Malta aimed at transforming the understanding and care of Parkinson’s in Malta.

The project was launched by Parliamentary Secretary for Youth, Research and Innovation Keith Azzopardi Tanti, and represents more than just a research study. It is a strategic step to position Malta shoulder to shoulder with leading European centres in medical excellence.

Led by Professor Neville Vassallo, “MINDS” will focus on studying the condition at a molecular level, a crucial step towards developing more effective and personalised treatments, while also laying the groundwork for new medicines driven by Maltese talent.

The initiative complements the support already offered by Government, including free medication and complex interventions such as Deep Brain Stimulation.

Around 3,000 people in Malta live with Parkinson’s. Addressing this, Azzopardi Tanti described the project as a clear commitment towards both patients and the country’s long term vision.

“Our vision is clear: to make Life Sciences and Health a key pillar of Malta’s future as part of Vision 2050. Through ‘MINDS’, we are investing in excellence and equipping Maltese researchers with the tools to unlock new medical solutions,” he said.

Parkinson’s ambassador and Step Up for Parkinson’s deputy chairman Adrian Casha shared his personal experience, highlighting both the daily realities of the condition and the importance of continued research and innovation.

“Despite the challenges and stigma that still exist, research and technology are making a real difference. I hope ‘MINDS’ opens new horizons so people with Parkinson’s can live better lives,” he said.

Professor Vassallo emphasised the importance of biomedical research in Malta, noting that understanding the disease at its most fundamental level is essential to driving real progress.

“Research at molecular level is the first step towards developing treatments that are not only more effective but also tailored to patients,” he explained.

“MINDS” comes at a significant time as the world prepares to mark World Parkinson’s Day on April 11. This investment reflects the Government’s continued commitment to offering new hope and full support to patients and their families, while strengthening Malta’s position as a centre for innovation and research.

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted